| 451. | | | Hospital acquired pneumonia: Comparison of culture and real-time PCR assays for detection of Legionella pneumophila from respiratory specimens at Tehran Hospitals
|
| 452. | | | HTLV-I-related retroviral markers in Hungarian patients with mycosis fungoides
|
| 453. | | | Human coronavirus OC43 and other respiratory viruses from acute respiratory infections of Egyptian children
|
| 454. | | | Human cytomegalovirus load in the peripheral blood determined by quantitative competitive polymerase chain reaction
|
| 455. | | | Human enterovirus 109 (EV109) in acute paediatric respiratory disease in Hungary
|
| 456. | | | Human herpesvirus 6A and 6B and NK cells
|
| 457. | | | Human papilloma viruses in non-melanoma skin cancers : a short review
|
| 458. | | | Human vomeronasal epithelium development: An immunohistochemical overview
|
| 459. | | | Hyperproliferation of normally quiescent keratinocytes in non-lesional psoriatic skin due to high calcium concentration : an organotypic culture model
|
| 460. | | | Hypervirulent Klebsiella pneumoniae: An update on epidemiology, detection and antibiotic resistance
|
| 461. | | | Identification and antifungal susceptibility of Saprochaete clavata from invasive infections in Turkey
|
| 462. | | | Identification and characterization of CTX-M-15 producing Klebsiella pneumoniae clone ST101 in a Hungarian university teaching hospital
|
| 463. | | | Identification and incidence of fungal strains in chronic rhinosinusitis patients
|
| 464. | | | Identification of an intestinal microbiota signature associated with hospitalized patients with diarrhea
|
| 465. | | | Identification of enterococci isolated from cow's milk cheese: comparison of the classical methods and the API 20 strep system
|
| 466. | | | Identification of mutations in rpoB, pncA, embB, and ubiA genes among drug-resistant Mycobacterium tuberculosis clinical isolates from Iran
|
| 467. | | | Identification of NDM-1 producing and colistin resistant Klebsiella pneumoniae ST11: A highly drug-resistant strain detected in intensive care unit of a Greek tertiary care hospital
|
| 468. | | | Identification of two substrates of FTS_1067 protein - An essential virulence factor of Francisella tularensis
|
| 469. | | | Identification of virulence genes carried by bacteriophages obtained from clinically isolated methicillin-resistant Staphylococcus aureus
|
| 470. | | | IL-12 Family Cytokines: General Characteristics, Pathogenic Microorganisms, Receptors, and Signalling Pathways
|
| 471. | | | Imipenem resistance associated with amino acid alterations of the OprD porin in Pseudomonas aeruginosa clinical isolates
|
| 472. | | | Immune response to gut Escherichia coli and susceptibility to adjuvant arthritis in the rats
|
| 473. | | | Immune responses against chimeric DNA and protein vaccines composed of plpEN-OmpH and PlpEC-OmpH from Pasteurella multocida A:3 in mice
|
| 474. | | | Immune responses elicited by the recombinant Erp, HspR, LppX, MmaA4, and OmpA proteins from Mycobacterium tuberculosis in mice
|
| 475. | | | Immune responses to killed reassorted influenza virus supplemented with natural adjuvants
|
| 476. | | | Immunity and longevity
|
| 477. | | | Immunochemistry of adenoviruses: Limitations and new horizons of gene therapy
|
| 478. | | | The Immunoendocrine Thymus as a Pacemaker of Lifespan
|
| 479. | | | Immunoendocrinology: faulty hormonal imprinting in the immune system
|
| 480. | | | Immunological aspects of the effect of pentoxifylline (Trental) : A brief review
|
| 481. | | | Immunological responses to phospholipase-A of Salmonella typhi
|
| 482. | | | The immunomodulating effect of a new polyamine (the MAP-1987) administered with chloroquine in plasmodia infected mice
|
| 483. | | | Immunomodulating effect of acridine tautomers on eukaryotic cells
|
| 484. | | | Immunomodulatory effects of anti-microbial peptides
|
| 485. | | | The immunosuppressive effect of fusarium mycotoxin as a function of HLA antigens
|
| 486. | | | Immunotherapy : theoretical basis
|
| 487. | | | Impact of antimicrobial stewardship maturity on resistance and pediatric clinical outcomes: A multicenter cohort study
|
| 488. | | | The impact of gut microbiota modulation on responses to immune checkpoint inhibitors in cancer
|
| 489. | | | Impact of gut microbiota on immune system
|
| 490. | | | Imported Zika virus infections in Hungary between 2016 and 2018
|
| 491. | | | Improvement of tea leaves fermentation through pectinases
|
| 492. | | | In memoriam Dr. György Berencsi
|
| 493. | | | In memoriam István Földes (1921-2002)
|
| 494. | | | In memoriam Joseph L. Melnick (1914-2001)
|
| 495. | | | In memoriam Lajos Váczi (1917-2000)
|
| 496. | | | In Memoriam Professor Piroska Anderlik (1935?2018)
|
| 497. | | | In memoriam Zoltán Alföldy : 1904-1992
|
| 498. | | | In vitro activity of cefditoren against a special collection of clinical isolates of Streptococcus pneumoniae from Hungary
|
| 499. | | | In vitro activity of ceftazidime-avibactam, ceftolozane-tazobactam, imipenem-relebactam, meropenem-vaborbactam and cefiderocol against carbapenemase-producing Enterobacterales from clinical isolate...
|
| 500. | | | In vitro activity of ceftazidime-avibactam, imipenem-cilastatin-relebactam, meropenem-vaborbactam, cefiderocol, and plazomicin against non-fermenting Gram-negative isolates obtained from Bulgarian ...
|
